DNMT3A c.327del ;(p.Q110Rfs*52)

Variant ID: 2-25505430-GC-G

NM_022552.4(DNMT3A):c.327del;(p.Q110Rfs*52)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Blast cells surviving acute myeloid leukemia induction therapy are in cycle with a signature of FOXM1 activity.

Bmc Cancer
Williams, Mark S MS; Basma, Naseer J NJ; Amaral, Fabio M R FMR; Wiseman, Daniel H DH; Somervaille, Tim C P TCP
Publication Date: 2021-10-28

Variant appearance in text: DNMT3A: 327delG
PubMed Link: 34711181
Variant Present in the following documents:
  • 12885_2021_8839_MOESM2_ESM.xlsx, sheet 1
View BVdb publication page



appreci8: a pipeline for precise variant calling integrating 8 tools.

Bioinformatics (Oxford, England)
Sandmann, Sarah S; Karimi, Mohsen M; de Graaf, Aniek O AO; Rohde, Christian C; Göllner, Stefanie S; Varghese, Julian J; Ernsting, Jan J; Walldin, Gunilla G; van der Reijden, Bert A BA; Müller-Tidow, Carsten C; Malcovati, Luca L; Hellström-Lindberg, Eva E; Jansen, Joop H JH; Dugas, Martin M
Publication Date: 2018-12-15

Variant appearance in text: DNMT3A: 327delG; Gln110fs
PubMed Link: 29945233
Variant Present in the following documents:
  • bty518_supplementary_data_s2.xlsx, sheet 8
  • bty518_supplementary_data_s5.xlsx, sheet 8
  • bty518_supplementary_data_s6.xlsx, sheet 8
  • bty518_supplementary_data_s10.xlsx, sheet 8
View BVdb publication page